2017–19 governmental decisions to allow home use of misoprostol for early medical abortion in the UK
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 124 (7) , 679-683
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesContraception, 2019
- Impact of self-administration of misoprostol for early medical abortion: a prospective observational cohort studyBMJ Sexual & Reproductive Health, 2019
- The impact of Northern Ireland’s abortion laws on women’s abortion decision-making and experiencesBMJ Sexual & Reproductive Health, 2018
- Early medical abortion: best practice now lawful in Scotland and Wales but not available to women in EnglandBMJ Sexual & Reproductive Health, 2018
- Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostolJournal of Obstetrics and Gynaecology Research, 2018
- A direct‐to‐patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 monthsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2018
- Increasing Access to Abortion With TelemedicineJAMA Internal Medicine, 2016
- Provision of medical abortion using telemedicine in BrazilContraception, 2014
- Use of telemedicine for providing medical abortionInternational Journal of Gynecology & Obstetrics, 2013
- Acceptability of home-use of misoprostol in medical abortionContraception, 2004